Unmeasured confounders in RWD studies: an interview with Anirban Basu

In this feature, following participating in an Issue Panel at the International Society for Pharmacoeconomics and Outcomes Research’s 2021 virtual annual meeting (Virtual ISPOR 2021; 17–20 May), Anirban Basu (University of Washington, WA, USA) discusses challenges posed by unmeasured confounders in the context of comparative and real-world data (RWD) studies. Anirban Basu is a Professor of Health Economics and the Stergachis Family Endowed Director of The CHOICE Institute at the University of Washington, with joint appointments in Health Services and Economics. He is a Faculty Research Fellow at the National Bureau of Economic Research (MA, USA) and an elected Fellow...